KRPIA calls for reassessment of new drugs

Published: 2008-05-06 07:00:00

Updated: 2008-05-06 07:00:00

The Korea Research-based Pharmaceutical Industry Association (KRPIA) has urged the government to re-evaluate the ongoing assessment of antihyperlipemic agents as it failed to reflect expert opinions from related organizations.

The Health Insurance Review Agency is evaluating the economic effectiveness of those medicines to readjust prices and exclude items that are the least cost-effective. ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.